tiprankstipranks
Trending News
More News >
Astrana Health (ASTH)
NASDAQ:ASTH
US Market
Advertisement

Astrana Health (ASTH) Earnings Dates, Call Summary & Reports

Compare
255 Followers

Earnings Data

Report Date
Oct 30, 2025
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.46
Last Year’s EPS
0.33
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 07, 2025|
% Change Since: 36.67%|
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance in Q2 2025, significant growth, and successful acquisition strategies, despite some challenges in Medicaid and health insurance exchanges. The company is well-positioned to navigate these challenges with confidence in its strategic growth plans.
Company Guidance -
Q3 2025
During Astrana Health's Second Quarter 2025 Earnings Call, the company delivered strong financial performance with total revenues of $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of their guidance ranges. Revenue grew by 35% year-over-year, primarily due to the growth in the Care Partners segment. Approximately 78% of the revenue now comes from full risk contracts, up from 60% a year ago. The company reaffirmed its full year 2025 total revenue guidance of between $3.1 billion to $3.3 billion and adjusted EBITDA guidance of between $215 million and $225 million. Astrana Health also closed its acquisition of Prospect Health for $708 million, which contributed to an improved leverage position with a net debt to pro forma adjusted EBITDA leverage ratio of 2.7x, compared to the original estimate of 3.4x. The company expects further EBITDA expansion in 2026 as full risk cohorts mature and synergies from the Prospect integration ramp up. Astrana Health is committed to delivering sustainable long-term value and continues to manage cost trends effectively, with a full-year medical cost trend expectation of 4.5%.
Strong Revenue and EBITDA Growth
Total revenues for Q2 2025 were $654.8 million with an adjusted EBITDA of $48.1 million, representing a 35% year-over-year revenue growth, driven by the Care Partners segment and a shift to full risk arrangements.
Successful Prospect Health Acquisition
The acquisition of Prospect Health was closed at $708 million, down from the anticipated $745 million, reducing net debt to pro forma adjusted EBITDA leverage ratio to 2.7x, better than the original estimate of 3.4x.
Positive Outlook on Medicare Advantage
Expectations of further EBITDA expansion in 2026 as full risk cohorts mature, with no negative impact from the v28 risk model phase-in.
2025 Guidance Reaffirmed
Astrana Health reaffirmed its full-year 2025 guidance with total revenue between $3.1 billion to $3.3 billion and adjusted EBITDA between $215 million and $225 million.

Astrana Health (ASTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ASTH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 30, 2025
2025 (Q3)
0.46 / -
0.33
Aug 07, 2025
2025 (Q2)
0.35 / 0.19
0.4-52.50% (-0.21)
May 08, 2025
2025 (Q1)
0.21 / 0.14
0.31-54.84% (-0.17)
Feb 27, 2025
2024 (Q4)
0.10 / -0.15
0.26-157.69% (-0.41)
Nov 07, 2024
2024 (Q3)
0.31 / 0.33
0.47-29.79% (-0.14)
Aug 07, 2024
2024 (Q2)
0.39 / 0.40
0.2842.86% (+0.12)
May 07, 2024
2024 (Q1)
0.30 / 0.31
0.310.00% (0.00)
Feb 27, 2024
2023 (Q4)
0.15 / 0.26
-0.06533.33% (+0.32)
Nov 07, 2023
2023 (Q3)
0.33 / 0.47
0.56-16.07% (-0.09)
Aug 07, 2023
2023 (Q2)
0.25 / 0.28
0.2512.00% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ASTH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 07, 2025
$21.46$28.08+30.85%
May 08, 2025
$33.44$29.71-11.15%
Feb 27, 2025
$34.68$25.38-26.82%
Nov 07, 2024
$59.08$46.96-20.51%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Astrana Health (ASTH) report earnings?
Astrana Health (ASTH) is schdueled to report earning on Oct 30, 2025, TBA (Confirmed).
    What is Astrana Health (ASTH) earnings time?
    Astrana Health (ASTH) earnings time is at Oct 30, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ASTH EPS forecast?
          ASTH EPS forecast for the fiscal quarter 2025 (Q3) is 0.46.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis